Eli Lilly Is Better At Executing Now Than Novo Nordisk, Says Bmo's Evan Seigerman
Synopsis
Evan Seigerman, BMO head of health care research, joins 'The Exchange' to discuss the gap between Novo Nordisk and
You Might Also Like
Download Options
Choose a download method below. All links open in new tabs.
| Service | Features | Action |
|---|---|---|
| Ssvid |
MP4 & MP3 • HD Quality • Browser Extension Available
|
Download |
| SaveFrom |
MP4 & MP3 • HD Quality • Browser Extension Available
|
Download |
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.